Monotherapy with α-Blocker or Phosphodiesterase 5 Inhibitor for Lower Urinary Tract Symptoms?

被引：2
|
作者：
Chapple, Christopher R. [1 ]
机构：
[1] Sheffield Teaching Hosp NHS Trust, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 05期
关键词：
BENIGN PROSTATIC HYPERPLASIA; ERECTILE DYSFUNCTION; TADALAFIL; SECONDARY; COMBINATION; MANAGEMENT; SILDENAFIL; ALFUZOSIN; SUPERIOR; EFFICACY;
D O I：
10.1016/j.eururo.2012.02.040
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：926 / 927
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study
    Lee, J. Y.
    Cho, S. Y.
    Oh, C. Y.
    Ha, U. S.
    Lee, S. H.
    Park, S. Y.
    Moon, H. S.
    Lee, S. W.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2011, 23 (06) : 249 - 256
  • [42] Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms
    Faydaci, Gokhan
    Kuyumcuoglu, Ugur
    Eryildirim, Bilal
    Aktas, Alper
    Tarhan, Fatih
    Tuncer, Murat
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (03) : 619 - 624
  • [43] Tadalafil for male lower urinary tract symptoms improves endothelial function
    Fukumoto, Kazuhiko
    Nagai, Atsushi
    Hara, Ryoei
    Fujii, Tomohiro
    Miyaji, Yoshiyuki
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (03) : 206 - 210
  • [44] Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Urinary Retention
    Alawamlh, Omar Al Hussein
    Goueli, Ramy
    Lee, Richard K.
    MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (02) : 301 - +
  • [45] Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction
    Kaplan, Steven A.
    Gonzalez, Ricardo R.
    Te, Alexis E.
    EUROPEAN UROLOGY, 2007, 51 (06) : 1717 - 1723
  • [46] Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis
    Cui, Jianwei
    Cao, Dehong
    Bai, Yunjin
    Wang, Jiahao
    Yin, Shan
    Wei, Wuran
    Xiao, Yunfei
    Wang, Jia
    Wei, Qiang
    FRONTIERS IN MEDICINE, 2021, 8
  • [47] Treatment of the lower urinary tract symptoms secondary to benign prostatic hyperplasia by phosphodiesterase type 5 inhibitors. Review article
    Caremel, R.
    Oger-Roussel, S.
    Behr-Roussel, D.
    Grise, P.
    Giuliano, F.
    PROGRES EN UROLOGIE, 2010, 20 (09): : 616 - 626
  • [48] CLINICAL AND URODYNAMIC RESULTS OF ALPHA BLOCKER DRUG TREATMENT IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC HYPERPLASIA
    Salinas, J.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2015, 68 (02): : 161 - 171
  • [49] Comparative study of tamsulosin, tadalafil, and combination of tamsulosin with tadalafil in the treatment of patients with lower urinary tract symptoms
    Mondal, Soumya
    Agarwal, Neeraj
    Pal, Dilip Kumar
    UROLOGICAL SCIENCE, 2024, 35 (02) : 90 - 94
  • [50] Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
    Dong, Yang
    Hao, Lin
    Shi, Zhenduo
    Wang, Gang
    Zhang, Zhiguo
    Han, Conghui
    UROLOGIA INTERNATIONALIS, 2013, 91 (01) : 10 - 18
12345